Sensible Biotechnologies
THE CHALLENGE
Excitingly, they had secured a mention in the AI giant’s blog featuring Europe’s leading life science companies, published to coincide with the prestigious GTC innovation conference in Paris.
The problem? Their press release – which had already been approved by the NVIDIA team – was bland and boring, lacking a story hook that would appeal to journalists.
And there were just nine days to go from Sensible’s first message in our inbox to the blog’s publication date.
OUR APPROACH
We worked fast to onboard Sensible as a new client, and immediately started working closely with their leadership to rewrite the press release. Instead of a simple partnership announcement, we crafted a compelling story about the impact of NVIDIA’s AI technology on the pace of their mRNA design and optimisation pipeline.
We then pushed the revised press release through approval with NVIDIA in record time, pitching it to our hand-picked media list and getting it up on the newswire during the GTC conference to capitalise on the blog mention.
A few weeks later we ran a second campaign announcing a new partnership between Sensible and leading biologics manufacturer Sartorius Stedim Biotech.
Again, we polished the press release and sent it out to our list and the newswire – fortunately with a bit less time pressure! – building on the momentum and interest from the previous story.
Both stories landed with impact, gaining international media coverage and leading to several follow-up requests for interviews with the senior team.
The resulting buzz helped to attract the attention of investors and the wider biotech community at a crucial stage in Sensible’s journey.
KEY RESULTS
Rapid onboarding and campaign turnaround
Navigated high level stakeholders under pressure
Coverage across international life science media
Raised awareness of Sensible at a crucial stage in their journey
WHAT THEY SAID
“First Create The Media pulled off a miracle, turning our release into an attention-grabbing story in record time. The coverage helped to get us noticed by investors and the wider biotech community at the right time for our strategy.”
FIND OUT ABOUT SOME OF OUR OTHER WORK
Helping an ambitious biotech startup stand out from the crowd
Oxford-based techbio startup Scripta Therapeutics had closed a $12 million seed funding round to build their innovative drug discovery platform. It was time to come out of stealth mode and grab the world’s attention with an eye-catching brand, website, and PR...
How we translated complex science into a high-value lead generation asset
Particology needed to grow their new business pipeline, and were looking for help communicating their highly technical science in a way that would help them stand out and showcase their expertise to their target audiences. They wanted a clear, professional marketing...
A bit of everything: Flexible, wide-ranging comms & marketing support for a growing life science company
Depixus first approached us in 2022 looking for help producing marketing materials that clearly articulated the technology and benefits of their highly innovative large-scale magnetic force spectroscopy platform for measuring individual biomolecular interactions. It...
Flexible, high-quality science content support for a busy marketing team
Biognosys is a leader in the proteomics space, providing cutting edge products and services to the global research community. As the business grew, so did the demand for high-quality content to increase brand awareness, generate leads, and drive sales. However, their...
Turning public opinions into compelling messaging
The Campaign for Science and Engineering (CaSE) believes that the UK should celebrate and invest in research and development (R&D). But without the public feeling the same way, R&D investment is unlikely to be a political priority. CaSE’s Discovery Decade...
Raising the profile of a rebellious research funder
Despite being the only UK research funder solely dedicated to ageing research The Dunhill Medical Trust (now the Vivensa Foundation) was struggling to reach their target grantee audiences, resulting in applications that weren’t quite the right fit. Following the...